Inactive

The scope of work for this contract (across the Base and Option periods) includes the manufacture and delivery of up to 1.7 Million Treatment Courses (TCs) of the smallpox antiviral TEMBEXA, comprisin... The scope of work for this contract (across the Base and Option periods) includes the manufacture and delivery of up to 1.7 Million Treatment Courses (TCs) of the smallpox antiviral TEMBEXA, comprising oral tablets and oral suspension formulation to the SNS and the associated activities.